AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Orocobre Ltd (ASX:ORE)
Orocobre Ltd (ASX:ORE) is a leading ASX listed company which is producing high grade, high value lithium chemicals for the growing global battery and technical markets. The company recently revealed that the companyâs production from Olaroz Lithium Facility for the September quarter increased by 7 percent to 2,293 tonnes of lithium carbonate as compared to the previous corresponding period, however, it was down by 36% compared to the June quarter due to lower seasonal evaporation and a scheduled two-week maintenance outage. The company achieved the Quarterly sales revenue of US$32 million, which is 36% higher as compared to the previous corresponding period. Company reported that the overall sales volume of Borax Argentina in the September quarter was decreased by 11% to 9,407 tonnes as compared to the June quarter. The company is expecting that the full year production of FY19 will be higher than FY18. The company is also having a high expectation from the December quarter as production is believed to be up than what was noted in September quarter. In FY 2018, the company reported Record underlying net profit of US$25.7 million. Â
In the last six months, the share price of the company decreased by 33.57 percent as on 1 November 2018, and traded at a very high PE level of 332.140x. OREâs shares traded at $4.190 (+12.634% intraday) with a market capitalization of circa $972.44 million as on 2 November 2018.
Galaxy Resources Ltd (ASX:GXY)
Galaxy Resources Ltd (ASX:GXY) recently reported that the total mining volumes from Mt Cattlin Operations decreased by 8 percent in the September quarter compared to previous quarter resulting from a delay in receiving permits to allow planned mining access east of Floater Road. During the September quarter, the Company started an approximately 30,000m drill program to support the exploration, resource and reserve development at Mt Cattlin. Galaxy Resources has also bagged a binding agreement with POSCO; and this is with regards to sale of a package of tenements that are located in Argentina. The group has earmarked this transaction for a total cash consideration of about US $ 280 million.
As at 30 June 2018, the company was having cash of $45.1 million with zero debt. In the first half of FY 2018, the company reported the revenue of $88.4 million which is 682 percent higher than the corresponding previous period. The EBITDA of the company increased by 2,878% to $42.4M as compared to corresponding previous period due to an increase in the average realized price of US$90/dmt and a reduction in share-based payment expense of US$6.1m. The average cash margin per dmt sold increased by 140% over the previous half-year mainly due to higher realized selling price. A total of 6 shipments were completed in the first half of FY18 for an aggregate 90,019 dmt of product sold.
In the last six months the share price of the company decreased by 27.62 percent as on 1 November 2018, and it traded at a PE level of 37.190x. GXYâs shares traded at $2.580 (up 13.2%) with a market capitalization of circa $929.15 million as on 2 November 2018.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
